Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) appears in 54 institutional 13F filings for the quarter ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BML Capital Management, LLC | 31 Mar, 2026 | 3,167,231 | 0 | 0.00% | $10,768,585.00 |
| BML Capital Management, LLC | 31 Mar, 2026 | 3,167,231 | 0 | 0.00% | $9,026,608.00 |
| Aquamarine Financial (Cayman) Ltd | 31 Mar, 2026 | 2,112,312 | 139,255 | 7.06% | $7,181,861.00 |
| Aquamarine Financial (Cayman) Ltd | 31 Mar, 2026 | 1,973,057 | 0 | 0.00% | $5,623,212.00 |
| MERCER GLOBAL ADVISORS INC /ADV | 31 Mar, 2026 | 1,910,540 | 1,910,540 | 0.00% | $6,495,836.00 |
| SB Capital Management Inc | 31 Mar, 2026 | 1,900,000 | 1,900,000 | 0.00% | $5,415,000.00 |
| Gem Investment Advisors, LLC | 31 Mar, 2026 | 1,640,069 | -358,733 | -17.95% | $5,576,235.00 |
| Murchinson Ltd. | 31 Mar, 2026 | 1,340,247 | -411,312 | -23.48% | $3,819,704.00 |
| Murchinson Ltd. | 31 Mar, 2026 | 1,315,294 | -24,953 | -1.86% | $4,472,000.00 |
| BOOTHBAY FUND MANAGEMENT, LLC | 31 Mar, 2026 | 612,160 | -233,231 | -27.59% | $1,744,656.00 |
| BOOTHBAY FUND MANAGEMENT, LLC | 31 Mar, 2026 | 600,716 | -11,444 | -1.87% | $2,042,434.00 |
| Rathbones Group PLC | 31 Mar, 2026 | 466,036 | 233,018 | 100.00% | $1,328,202.00 |
| MARSHALL WACE, LLP | 31 Mar, 2026 | 259,611 | 556 | 0.21% | $882,677.00 |
| MARSHALL WACE, LLP | 31 Mar, 2026 | 259,055 | 259,055 | 0.00% | $738,308.00 |
| Rathbones Group PLC | 31 Mar, 2026 | 233,018 | -233,018 | -50.00% | $792,261.00 |
| CITADEL ADVISORS LLC | 31 Mar, 2026 | 196,020 | 84,313 | 75.48% | $558,657.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Mar, 2026 | 158,209 | 7,738 | 5.14% | $537,735.00 |
| Wells Fargo & Company/Mn | 31 Mar, 2026 | 157,586 | 27,000 | 20.68% | $535,791.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Mar, 2026 | 150,471 | 2,984 | 2.02% | $428,843.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Mar, 2026 | 147,700 | 200 | 0.14% | $502,180.00 |